Hostname: page-component-745bb68f8f-b6zl4 Total loading time: 0 Render date: 2025-01-10T17:00:42.022Z Has data issue: false hasContentIssue false
  • English
  • Français

Effectiveness of alteplase infusion for the management of prosthetic mitral valve thrombosis in paediatric age group and proposed algorithm

Published online by Cambridge University Press:  03 June 2022

Mohamed H Mashali Open the ORCID record for Mohamed H Mashali [Opens in a new window] ,
Zaheer Ahmad ,
Mohammed Omar Galal  and
Amjad Al-Kouatli
Mohamed H Mashali*
Affiliation:
Paediatric Cardiology Department, King Faisal Specialist Hospital and Research centre, Jeddah, Saudi Arabia Department of Paediatrics, Faculty of medicine, Cairo University, Cairo, Egypt
Zaheer Ahmad
Affiliation:
Paediatric Cardiology Department, King Faisal Specialist Hospital and Research centre, Jeddah, Saudi Arabia
Mohammed Omar Galal
Affiliation:
Paediatric Cardiology Department, King Faisal Specialist Hospital and Research centre, Jeddah, Saudi Arabia
Amjad Al-Kouatli
Affiliation:
Paediatric Cardiology Department, King Faisal Specialist Hospital and Research centre, Jeddah, Saudi Arabia
*
Author for correspondence: Mohamed Hesham Mashali, Department of Paediatric cardiology, King Faisal Specialist Hospital and Research centre, MBC J-16, P.O Box: 40047, Jeddah 21499, Saudi Arabia. Tel: 00966537452988; Fax: 0096614414839. E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Introduction:

The incidence of prosthetic valve implantation is increasing in the paediatric population. Prosthetic valve thrombosis leading to obstruction could potentially be a life-threatening complication. There is a debate regarding optimal management of this complication, and there is limited use of thrombolytic therapy in childhood in the setting of valve thrombosis.

Objective:

We aim to share our experience of successfully using fibrinolytic therapy in terms of alteplase for paediatric prosthetic mitral valve thrombosis and to propose a management algorithm.

Methods:

This retrospective analysis of the database was conducted at our hospital including patients who underwent thrombolysis (alteplase) for prosthetic mitral valve thrombosis from June, 2011 to June, 2021. A total of 10 patients with 20 attempts of alteplase infusion were found in our record.

Results:

Alteplase was successful in 19 attempts to relieve valve thrombosis. The safe and effective dose of alteplase was between 0.1 and 0.3 mg/kg/hour. There were no associated major bleeding complications and alteplase was administered either by central or peripheral line.

Conclusion:

Thrombolysis by alteplase infusion was found to be successful in relief of prosthetic mitral valve thrombosis in paediatric population without major bleeding complications.

Keywords

AlteplaseProsthetic mitral valveThrombosis
Type
Original Article
Information
Cardiology in the Young , Volume 33 , Issue 5 , May 2023 , pp. 747 - 753
Check for updates
Copyright
© The Author(s), 2022. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Biteker, M, Altun, I, Basaran, O, Dogan, V, Yildirim, B, Ergun, G. Treatment of prosthetic valve thrombosis: current evidence and future directions. J Clin Med Res 2015; 7: 932–936.CrossRefGoogle ScholarPubMed
Otto, CM, Nishimura, RA. et al. 2020 ACC/AHA Guideline for the management of patients with valvular heart disease: a report of the american college of cardiology/american heart association joint committee on clinical practice guidelines. Circulation 2021; 143: e72–e227.Google Scholar
Roudaut, R, Serri, K, Lafitte, S. Thrombosis of prosthetic heart valves: diagnosis and therapeutic considerations. Heart 2007; 93: 137–142.CrossRefGoogle ScholarPubMed
Huang, F, Lan, Y, Cheng, Z, Zhang, Z, Ren, F. Thrombolytic treatment of prosthetic valve thrombosis: a study using Urokinase. J Cardiothorac Surg 2020; 15: 286.CrossRefGoogle ScholarPubMed
Silber, H, Khan, SS, Matloff, JM, Chaux, A, DeRobertis, M, Gray, R. The St. Jude valve: thrombolysis as the first line of therapy for cardiac valve thrombosis. Circulation 1993; 87: 30–37.CrossRefGoogle ScholarPubMed
Vitale, N, Renzulli, A, Cerasuolo, F et al. Prosthetic valve obstruction: thrombolysis versus operation. Ann Thorac Surg 1994; 57: 365–370.CrossRefGoogle ScholarPubMed
Gürsoy, M, Kalçık, M, Yesin, M et al. A global perspective on mechanical prosthetic heart valve thrombosis: diagnostic and therapeutic challenges. Anatol J Cardiol 2016; 16: 980–989.Google ScholarPubMed
El-Segaier, M, Khan, M, Khan, Z, Momenah, T, Galal, MO. recombinant tissue plasminogen activator in the treatment of neonates with intracardiac and great vessels thrombosis. Pediatr Cardiol 2015; 36: 1582–1587.CrossRefGoogle ScholarPubMed
Dillon, GM, Stevens, S, Dusenbury, WL, Massaro, L, Toy, F, Purdon, B. Choosing the Correct “-ase” in acute ischemic stroke: alteplase, tenecteplase, and reteplase. Adv Emerg Nurs J 2019; 41: 271–278.CrossRefGoogle ScholarPubMed
Bivard, A, Lin, L, Parsonsb, MW. Review of stroke thrombolytics. J Stroke 2013; 15: 90–98.CrossRefGoogle ScholarPubMed
Dangas, G, Weitz, J, Giustino, G, Makkar, R, Mehran, R. Prosthetic heart valve thrombosis. JACC. 2016; 68: 2670–2689.CrossRefGoogle ScholarPubMed
Ootaki, Y, Yamaguchi, M, Yoshimura, N, et al. A successful thrombolytic therapy for thrombosed ATS valve in the mitral position in a child; report of a case. Kyobu geka. Japanese J Thorac Surg. 2003; 56: 790–792.Google Scholar
Özkan, M, Gündüz, S, Gürsoy, OM et al. A novel strategy in the management of prosthetic mechanical valve thrombosis and the predictors of outcome: the ultra-slow PROMETEE trial. Am Heart J. 2015; 170: 409–418.CrossRefGoogle ScholarPubMed
Ferrari, F, Vagnarelli, F, Gargano, G, et al. Early intracardiac thrombosis in preterm infants and thrombolysis with recombinant tissue type plasminogen activator. Arch Dis Child Fetal Neonatal Ed 2001; 85: F66–F69.CrossRefGoogle ScholarPubMed
Knirsch, W, Nadal, D. Infective endocarditis in congenital heart disease. Eur J Pediatr 2011; 170: 1111–1127.CrossRefGoogle ScholarPubMed
Williams, M. Thrombolysis in children. Br J Haematol 2009; 148: 26–36.CrossRefGoogle ScholarPubMed
Karthikeyan, G, Senguttuvan, NB, Joseph, J, Devasenapathy, N, Bahl, VK, Airan, B. Urgent surgery compared with fibrinolytic therapy for the treatment of left-sided prosthetic heart valve thrombosis: a systematic review and meta-analysis of observational studies. Eur Heart J 2013; 34: 1557–1566.CrossRefGoogle ScholarPubMed
Castilho, FM, De Sousa, MR, Mendonça, AL, Ribeiro, AL, Cáceres-Lóriga, FM. Thrombolytic therapy or surgery for valve prosthesis thrombosis: systematic review and meta-analysis. J Thromb Haemost 2014; 12: 1218–1228.CrossRefGoogle ScholarPubMed
Baghai, M, Alphonso, N, Sundar, P, et al. Thrombolysis of a prosthetic mitral valve in a 50-day-old child. Interact Cardiovasc Thorac Surg 2003; 2: 592–594.CrossRefGoogle Scholar
Kogon, B, Kirshbom, P, Forbess, J, Kanter, K. Thrombolytic therapy for prosthetic valve thrombosis in children: two case reports and review of the literature. J Thorac Cardiovasc Surg 2004; 127: 1519–1522.CrossRefGoogle ScholarPubMed
Serpi, M, Schmidt, KG, Kreuz, W, Bucsenez, D, Springer, W, Hagl, S, et al. Thrombolysis of prosthetic heart valve thrombosis using recombinant tissue plasminogen activator (rt-PA) in infancy and children. Z Kardiol 2001; 90: 191–196.CrossRefGoogle Scholar
Cheung, E, Aponte-Patel, L, Bacha, L et al. Successful Treatment of Severe Mechanical Mitral Valve Thrombosis With Tissue Plasminogen Activator in a 7-Month-Old Infant. Pediatr Cardiol 2013; 34: 1903–1907.CrossRefGoogle Scholar
Yen, TA, Chen, YS, Chen, CA, Wang, CC, Chang, CI, Wu, ET et al. Fibrinolytic therapy in mechanical valve thrombosis in a one-year-old girl. Circulation 2010; 121: e244–e245.CrossRefGoogle Scholar
Tarango, C and Manco-Johnson, MJ. Pediatric Thrombolysis: A Practical Approach. Front Pediatr 2017; 5: 260.CrossRefGoogle ScholarPubMed